Log in to save to my catalogue

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3550fcc6a6154e098ee7a4d7637069e6

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

About this item

Full title

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Case reports in cardiology, 2018-01, Vol.2018 (2018), p.1-4

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejec...

Alternative Titles

Full title

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3550fcc6a6154e098ee7a4d7637069e6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3550fcc6a6154e098ee7a4d7637069e6

Other Identifiers

ISSN

2090-6404

E-ISSN

2090-6412

DOI

10.1155/2018/3953579

How to access this item